Researchers developed a dual-modality imaging system that combines high-resolution structural and chemical analysis with AI to improve skin cancer diagnosis.
Key Details
- 1The system merges line-field confocal optical coherence tomography (LC-OCT) with confocal Raman microspectroscopy.
- 2Over 330 nonmelanoma skin cancer samples were examined in a year-long clinical study.
- 3AI models trained on chemical spectra achieved classification accuracy of 0.95 for basal cell carcinoma and 0.92 for both basal and squamous cell carcinoma.
- 4The approach allows targeted, noninvasive analysis of suspicious skin structures at cellular and molecular levels.
Why It Matters
This innovation promises less invasive, more accurate skin cancer diagnosis by combining structural and biochemical imaging with AI classification, potentially reducing reliance on biopsies and improving patient outcomes.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.